{"id":"W2265262314","doi":"10.1200/jco.2007.25.18_suppl.7678","title":"Cost-effectiveness analysis (CEA) of third-line erlotinib therapy compared to best supportive care for advanced non-small cell lung cancer (NSCLC) in British Columbia (BC)","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Erlotinib; Medicine; Oncology; Lung cancer; Internal medicine; Cost effectiveness; Docetaxel; Clinical endpoint; Cost-effectiveness analysis; Cancer; Surgery; Epidermal growth factor receptor; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004979271,0.0009251583,0.001981572,0.001642816,0.0002436451,0.001461719,0.0008965677,0.0007981437,0.002614548],"category_scores_gemma":[0.01611067,0.0004361793,0.004278493,0.001876463,0.0004456672,0.0007794492,0.0007668366,0.001155327,0.0001283329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01241983,"about_ca_system_score_gemma":0.004814699,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09949028,"about_ca_topic_score_gemma":0.08377147,"domain_scores_codex":[0.9939508,0.004071801,0.0003391855,0.0003602708,0.0007428851,0.0005349132],"domain_scores_gemma":[0.9930239,0.004552672,0.001127791,0.0001496512,0.0005598366,0.0005862076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.263976,0.003277074,0.2379761,0.009923103,0.04207562,0.0009588785,0.0003659843,0.2786158,0.002373661,0.00399609,0.008112249,0.1483494],"study_design_scores_gemma":[0.03333924,0.04447815,0.6053178,0.002315224,0.05023822,0.001467774,0.0009144066,0.2486712,0.00240591,0.00305919,0.00748169,0.0003111794],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742334,0.01431579,0.001160504,0.001007491,0.0000911496,0.001037322,0.00443497,0.00004597627,0.003673304],"genre_scores_gemma":[0.9968732,0.001065527,0.0004760832,0.00013544,0.00002248304,0.0002045447,0.0009477327,0.000005532516,0.0002695765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9005097,"threshold_uncertainty_score":0.1978224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08738385517410992,"score_gpt":0.5118081672593614,"score_spread":0.4244243120852515,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}